Expleo Solutions Intrinsic Value
Expleo Solutions intrinsic value. Expleo Solutions (EXPLEOSOL) median intrinsic value is ₹884.98 from 9 valuation models (range ₹485–₹1680), vs current price ₹863.45 — +2.5% upside (Trading Near Calculated Value), margin of safety 2.4%. For current market price and key ratios, visit EXPLEOSOL stock price BSE.
EXPLEOSOL Valuation Methods Summary — DCF, Graham Number & P/E
Expleo Solutions intrinsic value across 9 models vs current price ₹863.45 — upside/downside and value range per method. Compare with Expleo Solutions value estimation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1288.80 | ₹1031.04 - ₹1546.56 | +49.3% | EPS: ₹107.40, Sector P/E: 12x |
| Book Value Method | asset | ₹485.00 | ₹436.50 - ₹533.50 | -43.8% | Book Value/Share: ₹485.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹602.00 | ₹541.80 - ₹662.20 | -30.3% | Revenue/Share: ₹752.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹855.00 | ₹769.50 - ₹940.50 | -1.0% | EBITDA: ₹228.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1018.75 | ₹815.00 - ₹1222.50 | +18.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹687.36 | ₹618.62 - ₹756.10 | -20.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹884.98 | ₹796.48 - ₹973.48 | +2.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1680.00 | ₹1512.00 - ₹1848.00 | +94.6% | ROE: 21.6%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹970.00 | ₹873.00 - ₹1067.00 | +12.3% | EPS: ₹107.40, BVPS: ₹485.00 |
EXPLEOSOL Intrinsic Value vs Market Price — All Valuation Models
Expleo Solutions fair value range ₹485–₹1680 vs current market price ₹863.45 across 9 valuation models. Read Expleo Solutions dividend policy for the complete payout history and dividend yield track record.
EXPLEOSOL Intrinsic Value Analysis — Undervalued or Overvalued?
Expleo Solutions median intrinsic value ₹884.98, current price ₹863.45 — Trading Near Calculated Value by 2.5%, margin of safety 2.4%.
What is the intrinsic value of EXPLEOSOL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Expleo Solutions (EXPLEOSOL) is ₹884.98 (median value). With the current market price of ₹863.45, this represents a +2.5% variance from our estimated fair value.
The valuation range spans from ₹485.00 to ₹1680.00, indicating ₹485.00 - ₹1680.00.
Is EXPLEOSOL undervalued or overvalued?
Based on our multi-method analysis, Expleo Solutions (EXPLEOSOL) appears to be trading near calculated value by approximately 2.5%.
EXPLEOSOL Financial Health — Key Ratios vs Industry Benchmarks
Expleo Solutions financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 29.62 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 21.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.30x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
EXPLEOSOL Cash Flow Quality — Operating & Free Cash Flow
Expleo Solutions operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹120 Cr | ₹120 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹179 Cr | ₹154 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹71 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹23 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹24 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |